Rare lephants
Screener

Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 Mar 15, 2024 S-8
10-K Mar 13, 2024 10-K
8-K Mar 13, 2024 8-K
SC 13G Feb 14, 2024 SC 13G
8-K Feb 9, 2024 8-K
4 Feb 5, 2024 4
4 Feb 5, 2024 4
4 Feb 5, 2024 4
4 Feb 5, 2024 4
4 Feb 5, 2024 4
4 Feb 5, 2024 4
144 Feb 5, 2024
8-K Jan 8, 2024 8-K
8-K Jan 5, 2024 8-K
4 Jan 4, 2024 4
8-K Jan 2, 2024 8-K
4 Nov 15, 2023 4
3 Nov 15, 2023 3
S-8 Nov 13, 2023 S-8
S-8 Nov 13, 2023 S-8
8-K Nov 13, 2023 8-K
10-Q Nov 13, 2023 10-Q
8-K Nov 1, 2023 8-K
8-K/A Oct 16, 2023 8-K/A
4 Oct 10, 2023 4
← Newer Page 5 of 21 · 513 filings Older →